Phibro Animal Health | PAHC - Ordinary Share Capital


Phibro Animal Health reported $40.48M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Align Technology USD 71.62M 133K Mar/2026
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Henry Schein USD 114.42M 1.35M Mar/2026
Idexx Laboratories USD 79.24M 611K Mar/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Merck USD 2.47B 12.72M Dec/2025
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Pacira USD 39.31M 1.81M Mar/2026
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 47.32M 765K Dec/2025
Supernus Pharmaceuticals USD 58.04M 582K Mar/2026
Zoetis USD 420.35M 4.58M Mar/2026